Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Jan-22 12:18 PM View:  | McKenzie W Thorpe Director 10% Owner | Xbiotech Inc. (XBIT) | 16-Dec-21 | Option Exercise | 250,000 | $10.00 | $2,500,000.00 | 10% 2.56M to 2.81M | |
| 13-Jan-22 12:18 PM View: | McKenzie W Thorpe Director 10% Owner | Xbiotech Inc. (XBIT) | 16-Dec-21 | Payment of Exercise | 213,493 | $11.71 | $2,500,000.00 | (8%) 2.81M to 2.6M | |
| 15-Feb-22 4:05 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 18-Oct-21 | Market Sale | 33,000 | $13.07 | $431,254.00 | (< 1%) 3.86M to 3.82M | 11% |
| 15-Feb-22 4:05 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 15-Oct-21 | Market Sale | 17,000 | $13.32 | $226,471.00 | (< 1%) 3.87M to 3.86M | 13% |
| 15-Oct-21 12:26 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 14-Oct-21 | Market Sale | 21,125 | $12.90 | $272,523.00 | (< 1%) 3.89M to 3.87M | (2%) |
| 15-Oct-21 12:26 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 13-Oct-21 | Market Sale | 10,875 | $12.83 | $139,526.00 | (< 1%) 3.97M to 3.96M | (2%) |
| 15-Oct-21 12:26 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 12-Oct-21 | Market Sale | 18,000 | $12.77 | $229,939.00 | (< 1%) 3.99M to 3.97M | (3%) |
| 15-Oct-21 12:26 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 07-Oct-21 | Market Sale | 39,286 | $12.45 | $489,111.00 | (< 1%) 3.96M to 3.92M | (5%) |
| 06-Oct-21 5:48 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 06-Oct-21 | Market Sale | 10,714 | $12.53 | $134,259.00 | (< 1%) 3.97M to 3.96M | 1% |
| 06-Oct-21 5:48 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 05-Oct-21 | Market Sale | 14,218 | $12.66 | $180,058.00 | (< 1%) 3.99M to 3.97M | 2% |
| 06-Oct-21 5:48 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 04-Oct-21 | Market Sale | 23,681 | $13.08 | $309,864.00 | (< 1%) 4.01M to 3.99M | 5% |
| 01-Oct-21 4:39 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 01-Oct-21 | Market Sale | 19,684 | $13.23 | $260,488.00 | (< 1%) 4.03M to 4.01M | 2% |
| 01-Oct-21 4:39 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 30-Sep-21 | Market Sale | 18,558 | $13.07 | $242,464.00 | (< 1%) 4.05M to 4.03M | < 1% |
| 01-Oct-21 4:39 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 29-Sep-21 | Market Sale | 16,396 | $13.41 | $219,802.00 | (< 1%) 4.07M to 4.05M | 3% |
| 01-Oct-21 4:39 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 28-Sep-21 | Market Sale | 6,263 | $14.27 | $89,363.60 | (< 1%) 4.07M to 4.07M | 9% |
| 28-Sep-21 10:59 AM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 27-Sep-21 | Market Sale | 29,890 | $14.81 | $442,790.00 | (< 1%) 4.1M to 4.07M | (< 1%) |
| 28-Sep-21 10:59 AM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 24-Sep-21 | Market Sale | 11,418 | $14.49 | $165,409.00 | (< 1%) 4.11M to 4.1M | (3%) |
| 28-Sep-21 10:59 AM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 23-Sep-21 | Market Sale | 9,892 | $14.68 | $145,220.00 | (< 1%) 4.12M to 4.11M | (1%) |
| 22-Sep-21 10:00 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 22-Sep-21 | Market Sale | 19,669 | $15.14 | $297,757.00 | (< 1%) 4.14M to 4.12M | 5% |
| 22-Sep-21 10:00 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 21-Sep-21 | Market Sale | 16,860 | $15.24 | $256,913.00 | (< 1%) 4.16M to 4.14M | 6% |
| 22-Sep-21 10:00 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 20-Sep-21 | Market Sale | 13,471 | $15.06 | $202,914.00 | (< 1%) 4.17M to 4.16M | 5% |
| 19-Jul-21 2:27 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 14-Jul-21 | Market Sale | 50,000 | $18.15 | $907,350.00 | (1%) 4.22M to 4.17M | (4%) |
| 12-Jul-21 11:10 AM View: | MacAdam Donald H. Director | Xbiotech Inc. (XBIT) | 09-Jul-21 | Option Exercise | 10,000 | $4.40 | $44,000.00 | 100% 0 to 10.0K | |
| 12-Jul-21 11:48 AM View: | Libby Peter Director | Xbiotech Inc. (XBIT) | 09-Jul-21 | Option Exercise | 25,000 | $7.76 | $194,000.00 | 100% 0 to 25.0K | |
| 22-Mar-21 2:20 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 22-Mar-21 | Option Exercise | 500,000 | $7.50 | $3,750,000.00 | 13% 3.72M to 4.22M | (7%) |
| 18-Dec-20 10:39 AM View: | Bay Street Financial S.A. 10% Owner | Xbiotech Inc. (XBIT) | 18-Dec-20 | Market Sale | 1,173,030 | $18.78 | $22,029,600.00 | (37%) 3.15M to 1.98M | (1%) |
| 02-Dec-20 10:54 AM View: | Bay Street Financial S.A. 10% Owner | Xbiotech Inc. (XBIT) | 02-Dec-20 | Market Sale | 182,836 | $18.42 | $3,367,840.00 | (5%) 3.34M to 3.15M | (3%) |
| 20-Nov-20 12:47 PM View: | McKenzie W Thorpe Director 10% Owner | Xbiotech Inc. (XBIT) | 19-Nov-20 | Market Sale | 375,000 | $18.30 | $6,862,500.00 | (12%) 3.04M to 2.67M | (4%) |
| 21-Sep-20 5:07 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 18-Sep-20 | Disposition (other) | 500,000 | -- | -- | (12%) 4.22M to 3.72M | |
| 16-Sep-20 4:22 PM View: | Shivaswamy Sushma Chief Scientific Officer | Xbiotech Inc. (XBIT) | 15-Sep-20 | Option Exercise | 20,668 | $7.50 | $155,010.00 | 100% 0 to 20.67K | |
| 16-Sep-20 4:22 PM View: | Shivaswamy Sushma Chief Scientific Officer | Xbiotech Inc. (XBIT) | 15-Sep-20 | Market Option Sale | 20,668 | $20.00 | $413,360.00 | (100%) 20.67K to 0 | 5% |
| 16-Sep-20 4:22 PM View: | Shivaswamy Sushma Chief Scientific Officer | Xbiotech Inc. (XBIT) | 10-Sep-20 | Option Exercise | 19,332 | $7.50 | $144,990.00 | 100% 0 to 19.33K | (7%) |
| 16-Sep-20 4:22 PM View: | Shivaswamy Sushma Chief Scientific Officer | Xbiotech Inc. (XBIT) | 10-Sep-20 | Market Option Sale | 19,332 | $20.01 | $386,833.00 | (100%) 19.33K to 0 | 5% |
| 02-Sep-20 11:33 AM View: | Han Queena VP Finance & HR | Xbiotech Inc. (XBIT) | 01-Sep-20 | Option Exercise | 57,692 | $4.20 | $242,399.00 | 100% 0 to 57.69K | |
| 26-Aug-20 1:35 PM View: | Han Queena VP Finance & HR | Xbiotech Inc. (XBIT) | 24-Aug-20 | Option Exercise | 51,841 | $6.67 | $346,000.00 | 100% 0 to 51.84K | 5% |
| 26-Aug-20 1:35 PM View: | Han Queena VP Finance & HR | Xbiotech Inc. (XBIT) | 24-Aug-20 | Market Option Sale | 51,841 | $19.65 | $1,018,900.00 | (100%) 51.84K to 0 | 3% |
| 21-Aug-20 2:56 PM View: | Han Queena VP Finance & HR | Xbiotech Inc. (XBIT) | 17-Aug-20 | Market Option Sale | 1,300 | $19.30 | $25,090.00 | (50%) 2.6K to 1.3K | 1% |
| 21-Aug-20 2:56 PM View: | Han Queena VP Finance & HR | Xbiotech Inc. (XBIT) | 17-Aug-20 | Option Exercise | 1,300 | $7.50 | $9,750.00 | 100% 1.3K to 2.6K | (7%) |
| 25-Mar-20 10:09 AM View: | Bay Street Financial S.A. 10% Owner | Xbiotech Inc. (XBIT) | 19-Feb-20 | Sale | 1,662,620 | $6.38 | $10,607,500.00 | (33%) 5.0M to 3.34M | (10%) |
| 13-Feb-20 4:44 PM View: | McKenzie W Thorpe Director 10% Owner | Xbiotech Inc. (XBIT) | 12-Feb-20 | Disposition | 1,401,860 | $30.00 | $42,055,700.00 | (31%) 4.56M to 3.16M | |
| 14-Feb-20 3:05 PM View: | Gut Thomas 10% Owner | Xbiotech Inc. (XBIT) | 12-Feb-20 | Disposition | 1,868,870 | $30.00 | $56,066,100.00 | (32%) 5.86M to 4.0M | |
| 13-Feb-20 4:48 PM View: | Simard John Chief Executive Officer Director 10% Owner | Xbiotech Inc. (XBIT) | 12-Feb-20 | Disposition | 2,016,470 | $30.00 | $60,494,000.00 | (32%) 6.33M to 4.31M | |
| 13-Feb-20 4:52 PM View: | Waldin Jan-Paul Director | Xbiotech Inc. (XBIT) | 12-Feb-20 | Disposition | 95,612 | $30.00 | $2,868,360.00 | (32%) 300.0K to 204.39K | |
| 13-Feb-20 4:44 PM View: | McKenzie W Thorpe Director 10% Owner | Xbiotech Inc. (XBIT) | 12-Feb-20 | Disposition | 50,749 | $30.00 | $1,522,470.00 | (2%) 3.16M to 3.11M | |
| 13-Feb-20 5:07 PM View: | Rennes Foundation 10% Owner | Xbiotech Inc. (XBIT) | 03-Feb-20 | Gift | 5,000,000 | -- | -- | (98%) 5.11M to 110.28K | |
| 09-Jan-20 4:19 PM View: | McKenzie W Thorpe Director 10% Owner | Xbiotech Inc. (XBIT) | 06-Jan-20 | Option Exercise | 123,000 | $3.75 | $461,250.00 | 3% 3.74M to 3.87M | |
| 04-Dec-19 3:29 PM View: | McKenzie W Thorpe Director 10% Owner | Xbiotech Inc. (XBIT) | 29-Nov-19 | Option Exercise | 185,000 | $3.75 | $693,750.00 | 5% 3.56M to 3.74M | |
| 06-Sep-18 4:35 PM View: | McKenzie W Thorpe Director 10% Owner | Xbiotech Inc. (XBIT) | 06-Sep-19 | Sale | 7,159 | $3.69 | $26,396.70 | (< 1%) 4.0M to 3.99M | |
| 06-Jun-19 10:36 AM View: | Rennes Foundation 10% Owner | Xbiotech Inc. (XBIT) | 04-Jun-19 | Market Purchase | 1,200,000 | $8.25 | $9,900,000.00 | 31% 3.91M to 5.11M | 131% |
| 05-Mar-19 4:25 PM View: | Rennes Foundation 10% Owner | Xbiotech Inc. (XBIT) | 04-Mar-19 | Private Purchase | 16,426 | $7.91 | $129,930.00 | < 1% 3.89M to 3.91M |
